Sears Capital Management - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $87,545.32 +6.46%
Ethereum $3,289.81 +2.67%
BNB $628.95 +0.32%
Optimism $1.69 +0.65%
Arbitrum $0.63 -0.45%
Solana $212.23 -2.78%
Polygon $0.40 -2.64%
Cosmos $5.39 +0.64%
Avalanche $34.85 +8.18%

Bitcoin $87,545.32 +6.46%
Ethereum $3,289.81 +2.67%
BNB $628.95 +0.32%
Optimism $1.69 +0.65%
Arbitrum $0.63 -0.45%
Solana $212.23 -2.78%
Polygon $0.40 -2.64%
Cosmos $5.39 +0.64%
Avalanche $34.85 +8.18%

Sears Capital Management

investment firm

Summary
Investments
Exits
Employees

About

Sears Capital Management is a venture investment and portfolio management firm focused on the life sciences industry.

Cupertino,California,United States
http://www.searscapital.net

Highlights

Lead Investments

Employee Profiles

Details

Founded date: Jan 1, 1994
Operating Status: Active
Investor Type: Venture Capital

Investments

Number of Investments

Number of Lead Investments

8

1

Sears Capital Management has made 8 investments. Their most recent investment was on Jan 6, 2017, when SiteOne Therapeutics raised $15M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Jan 6, 2017 SiteOne Therapeutics	Series B	$15M	Biotechnology	—
Jul 15, 2015 SiteOne Therapeutics	Series Unknown	$1.27M	Biotechnology	—
Sep 24, 2014 SiteOne Therapeutics	Series A	$1.50M	Biotechnology	Yes
Jan 29, 2013 CharlestonPharma,LLC	Seed	$1.60M	Biotechnology	—
Aug 4, 2008 InteKrin	Series C	$18.50M	Biotechnology	—

Show More

Employee Profiles

Number of Employee Profiles

2

Sears Capital Management has 2 current employee profiles, including Executive Lowell Sears

Executive

Board member

Exits

Sears Capital Management has had 3 exits. Sears Capital Management most notable exits include Anthera Pharmaceuticals , InteKrin

Date	Company Name	Exit Type	Industry
Jun 28, 2018	Anthera Pharmaceuticals	IPO	Biotechnology	Detail
Feb 12, 2014	InteKrin	M&A	Biotechnology	Detail
Apr 19, 2005	Peninsula Pharmaceuticals	M&A	Biopharma	Detail